ID
25654
Beskrivning
Study ID: 101468/228 Clinical Study ID: 101468/228 Study Title:A two year Phase IIIb randomised, multicenter, double-blind, SINEMET controlled, parallel group, flexible dose study, to assess the effectiveness of controlled release ropinirole add-on therapy to L-dopa at increasing the time to onset of dyskinesia in Parkinson's disease subjects. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00363727 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication : Dyskinesias; Parkinson Disease; Parkinson's Disease Study part: Non-serious adverse events
Nyckelord
Versioner (4)
- 2017-08-12 2017-08-12 -
- 2017-08-12 2017-08-12 -
- 2017-08-18 2017-08-18 -
- 2017-09-08 2017-09-08 -
Uppladdad den
8 september 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Non-serious adverse events GSK study Dyskinesia in Parkinson's disease NCT00363727
Non-serious adverse events GSK study Dyskinesia in Parkinson's disease NCT00363727
Beskrivning
Non-serious adverse events
Beskrivning
If Yes, record details below. Note: If this is a Serious Adverse Event (SAE), do not complete this form, go to the SAE section and complete the SAE form.
Datatyp
boolean
Alias
- UMLS CUI [1]
- C1518404
Beskrivning
Diagnosis Only (if known). Otherwise Sign/Symptom
Datatyp
text
Alias
- UMLS CUI [1]
- C0441471
Beskrivning
Start date
Datatyp
date
Alias
- UMLS CUI [1]
- C0808070
Beskrivning
Outcome
Datatyp
integer
Alias
- UMLS CUI [1]
- C1705586
Beskrivning
End Date
Datatyp
date
Alias
- UMLS CUI [1]
- C0806020
Beskrivning
Maximum Intensity
Datatyp
text
Alias
- UMLS CUI [1,1]
- C0518690
- UMLS CUI [1,2]
- C0877248
Beskrivning
Action Taken
Datatyp
text
Alias
- UMLS CUI [1]
- C2826626
Beskrivning
withdrawal
Datatyp
boolean
Alias
- UMLS CUI [1,1]
- C2349954
- UMLS CUI [1,2]
- C1519255
Beskrivning
AE caused by the investigational product
Datatyp
boolean
Alias
- UMLS CUI [1,1]
- C0085978
- UMLS CUI [1,2]
- C0877248
Similar models
Non-serious adverse events GSK study Dyskinesia in Parkinson's disease NCT00363727
C0678257 (UMLS CUI [1,2])
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
C0443172 (UMLS CUI-2)
(Comment:en)
C0178602 (UMLS CUI-2)
(Comment:en)
(Comment:en)
C1519255 (UMLS CUI [1,2])
C0877248 (UMLS CUI [1,2])